Susan Levine



Susan M. Levine, MD, works with ME/CFS patients at her medical office in New York City, New York, United States.

Dr. Levine is a clinician for the Center for Enervating NeuroImmune Disease at Cornell University, New York and is a member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University.

Education
(As per bio on Chronic Fatigue Initiative website. )
 * graduated from Albert Einstein School of Medicine in 1981
 * residency in Internal Medicine at Montefiore Hospital, Bronx, NYC
 * fellowship in Infectious Diseases at Memorial Sloan Kettering Cancer Center, NYC
 * fellowship in Allergy and Immunology at Mt. Sinai Hospital, NYC

IOM Committee on Diagnostic Criteria for ME/CFS
Dr Levine was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Chronic Fatigue Syndrome Advisory Committee
She served on the Chronic Fatigue Syndrome Advisory Committee (CFSAC) which advises the U.S. Department of Health and Human Services from 10 May 2010 to 10 May 2017, her term having been extended twice. From 2014 to 2017 she served as the committee chair.

Notable studies

 * 2018, KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial (Full Text)
 * 2018, Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome (Abstract)
 * 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome (Full Text)
 * 2016, Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome (Full Text)
 * 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome (Abstract)
 * 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study (Abstract)
 * 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness (Full Text)
 * 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus (Full Text)
 * 2004, Immunologic Aspects of Chronic Fatigue Syndrome: Report on a Research Symposium Convened by The CFIDS Association of America and Co-Sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health (Abstract)
 * 2001, Prevalence of IgM and IgG Antibody to HHV-6 and HHV-8 and Results of Plasma PCR to HHV-6 and HHV-7 in a Group of CFS Patients and Healthy Donors (Abstract)
 * 2001, Prevalence in the Cerebrospinal Fluid of the Following Infectious Agents in a Cohort of 12 CFS Subjects: Human Herpes Virus-6 and 8; Chlamydia Species; Mycoplasma Species; EBV; CMV; and Coxsackievirus
 * 1999, Borna Disease Virus Proteins in Patients with CFS

Clinic location

 * 115 E 72nd St.,
 * New York, NY 10021
 * Tel: (212) 472-4816

Talks & interviews

 * 20 Apr 2017, Solve ME/CFS Initiative Webinar - "A 360° Approach to Solve ME/CFS"
 * 17 Mar 2016, Solve ME/CFS Initiative Webinar - "The Future of ME/CFS"
 * Part 1 - Written questions and answers to Dr. Levine's webinar
 * Part 2 - Written questions and answers to Dr. Levine's webinar

Open Letter to The Lancet
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Levine, along with 41 colleagues in the ME/CFS field, signed the second letter.
 * 10 February 2016, An open letter to The Lancet, again - Virology blog

Online presence

 * Chronic Fatigue Initiative - Susan M. Levine, MD
 * PubMed - Susan Levine